Medea appoints NHS advisor
pharmafile | July 15, 2010 | Appointment | Medical Communications | Medea, appointment, medical communications
PR agency Medea Communications has engaged the former chair of a major hospital drugs and therapeutics committee to act as an expert consultant.
Dr Gilbert Park, until recently Chair of the Joint Drugs and Therapeutics committee at Addenbrooke’s Hospital, Cambridge will act in an advisory capacity to East Sheen, UK-based Medea, with specific focus on helping pharmaceutical companies to navigate the ever-changing NHS.
Medea’s managing director Kate Hawker said: “Pharmaceutical companies need to deliver robust cost justification evidence to persuade payors to invest in new drugs and Dr Park is in a unique position to advise companies about how to develop a successful business case for their products.”
Dr Park will also work with Medea to develop specific photographic and digital audio offerings designed to support industry dialogue with the NHS from his new state-of-the-art media studio in Cambridge.
Related Content

Men’s health – a new report from the Department of Health and Social Care
The UK Department of Health and Social Care has published a new report entitled Men’s …

PlasmidFactory founder Dr. Martin Schleef honoured with the NRW Innovation Award 2025
The founder and long-standing CEO of PlasmidFactory, Dr. Martin Schleef, was honoured in Düsseldorf with …

David Wheadon appointed to board of directors at Seaport Therapeutics
This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.






